指南与共识创伤与烧伤消化、代谢与肾脏急症

膝关节翻修手术的临床优先级:BASK工作组共识文件

Clinical prioritisation of revision knee surgical procedures: BASK working group consensus document.
指南 / 共识 · Knee · 2020-12-08
一句话结论BASK共识按NHS England/皇家学院(Royal College)量表将23种膝关节翻修场景分为P1a至P4四级,脓毒症和假体周围骨折手术最紧急。

英国膝关节外科协会(BASK)翻修膝关节工作组24名成员对23种翻修全膝关节置换术场景进行两轮投票,采用NHS England/皇家学院(Royal College)优先级量表评定。共识定义为≥70%受访者(18/24)给予相同优先级。18/23个手术达到共识。3个为P1a(<24小时内手术):脓毒症DAIR、假体周围骨折固定和假体周围骨折翻修TKA;3个为P1b(<72小时);8个为P2(<4周);5个为P3(<3个月);4个为P4(可等待>3个月)。脓毒症和假体周围骨折手术最紧急,但P4病例占大多数外科医生的工作量。

要点

  • 脓毒症DAIR、假体周围骨折固定和假体周围骨折翻修TKA为P1a,需在<24小时内手术。
  • 稳定患者DAIR、开放膝关节皮瓣覆盖和急性伸膝装置断裂为P1b,需在<72小时内手术。
  • 8个场景为P2(<4周),包括有塌陷风险的无菌性松动和间隔器功能差的间期患者。
  • 5个场景为P3(<3个月),包括感染二期翻修和活动受限的不稳定翻修。
  • 4个场景为P4(可等待>3个月),如无菌性松动,占大多数外科医生的工作量。

适用人群与场景

  • 需行翻修全膝关节置换术的择期骨科手术患者,在Covid-19大流行期间需进行病例优先级排序。

诊断标准与关键阈值

  • 共识定义:≥70%受访者(18/24)给予相同优先级即达成共识。
  • 优先级量表采用NHS England/皇家学院(Royal College)量表:P1a为<24小时内手术,P1b为<72小时内手术,P2为<4周内手术,P3为<3个月内手术,P4为可等待>3个月。

处置流程与药物剂量

  • P1a(<24小时):脓毒症DAIR、假体周围骨折固定、假体周围骨折翻修TKA。
  • P1b(<72小时):稳定患者DAIR、开放膝关节皮瓣覆盖、急性伸膝装置断裂。
  • P2(<4周):包括有塌陷风险的无菌性松动、间隔器功能差的间期患者等8个场景。
  • P3(<3个月):包括感染二期翻修、活动受限的不稳定翻修等5个场景。
  • P4(可等待>3个月):如无菌性松动等4个场景。

红旗征与不能漏的情况

  • 脓毒症和假体周围骨折手术为最紧急情况,需按P1a在<24小时内手术。

研究设计与关键结果

  • BASK翻修膝关节工作组24名成员对23种翻修TKA场景进行两轮投票,18/23个手术达到≥70%共识。
  • 3个场景为P1a(<24小时):脓毒症DAIR、假体周围骨折固定、假体周围骨折翻修TKA。
  • 3个场景为P1b(<72小时):稳定患者DAIR、开放膝关节皮瓣覆盖、急性伸膝装置断裂。
  • 8个场景为P2(<4周),5个为P3(<3个月),4个为P4(可等待>3个月)。
  • 未达70%共识的场景给予最常分配的优先级。

证据类型、等级与局限

  • 证据类型:专家共识(BASK工作组共识文件)。
  • 共识方法:24名成员两轮投票,≥70%受访者(18/24)给予相同优先级定义为达成共识。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些推荐为指南性质,患者合并症、Covid-19路径、支持服务可及性和区域翻修网络内多学科团队讨论将决定优先级排序。
  • 脓毒症和假体周围骨折手术应视为最紧急手术(P1a,<24小时)。
  • 大多数手术应在1至3个月内进行(P2/P3),但P4病例(如无塌陷风险的无菌性松动)占大多数外科医生的工作量。

指南或共识出处

  • BASK翻修膝关节工作组共识文件(Clinical prioritisation of revision knee surgical procedures: BASK working group consensus document),英国膝关节外科协会(British Association for Surgery of the Knee, BASK),原文未写明发布年份。

提炼说明

  • 本条依据论文摘要整理;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Elective orthopaedic surgery during the Covid-19 pandemic requires careful case prioritisation. We aimed to produce consensus-based guidelines on the prioritisation of revision total knee arthroplasty (TKA) procedures.

METHOD: Twenty-three revision TKA scenarios were assigned priority (NHS England/Royal College of Surgeons scale) by the British Association for Surgery of the Knee (BASK) Revision Knee Working Group (n = 24). Consensus agreement was defined as ≥70% respondents (18/24) giving the same prioritisation. Two voting rounds were undertaken; procedures achieving <70% agreement were given their most commonly assigned priority.

RESULTS: 18/23 procedures achieved ≥70% agreement. Three were P1a (surgery within <24 h); DAIR for sepsis, peri-prosthetic fracture (PPF) fixation and PPF-revision TKA. Three were P1b (<72 h); debridement, antibiotics and implant retention (DAIR) for a stable patient, flap coverage for an open knee, and acute extensor mechanism rupture. Eight were P2 (<4 weeks), including aseptic loosening at risk of collapse, inter-stage patients with poor functioning spacers. Five were P3 (<3 months), including second stage revision for infection, revision for instability with limited mobility. Four were P4 (can wait >3 months) e.g. aseptic loosening.

CONCLUSION: Sepsis and PPF surgery are the most urgent procedures. Although most procedures should be undertaken within one to three months (P2/3), these cases represent a small revision practice volume; P4 cases (e.g. aseptic loosening without risk of collapse) make up most surgeons' caseload. These recommendations are a guideline; patient co-morbidities, Covid-19 pathways, availability of support services and multi-disciplinary team discussion within the regional revision network will dictate prioritisation.

来源:Knee,查看原文。版权归原作者所有。

参考来源

  1. Kalson NS, Mathews JA, Toms AD, et al. Clinical prioritisation of revision knee surgical procedures: BASK working group consensus document. Knee. 2020. PMID: 33307320. doi:10.1016/j.knee.2020.10.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。